Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Clene (CLNN) Research & Development (2020 - 2025)

Clene (CLNN) has 6 years of Research & Development data on record, last reported at $3.5 million in Q3 2025.

  • For Q3 2025, Research & Development fell 21.43% year-over-year to $3.5 million; the TTM value through Sep 2025 reached $14.1 million, down 33.49%, while the annual FY2024 figure was $20.1 million, 24.75% down from the prior year.
  • Research & Development reached $3.5 million in Q3 2025 per CLNN's latest filing, roughly flat from $3.5 million in the prior quarter.
  • Across five years, Research & Development topped out at $9.5 million in Q4 2021 and bottomed at $1.5 million in Q1 2025.
  • Average Research & Development over 5 years is $6.1 million, with a median of $6.3 million recorded in 2021.
  • Peak YoY movement for Research & Development: surged 113.81% in 2021, then crashed 74.77% in 2025.
  • A 5-year view of Research & Development shows it stood at $9.5 million in 2021, then fell by 18.4% to $7.8 million in 2022, then decreased by 14.13% to $6.7 million in 2023, then fell by 16.56% to $5.6 million in 2024, then crashed by 36.91% to $3.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Research & Development were $3.5 million in Q3 2025, $3.5 million in Q2 2025, and $1.5 million in Q1 2025.